Know Cancer

or
forgot password

Genetic Analysis of Liver Cancer


N/A
18 Years
N/A
Not Enrolling
Male
Liver Cancer, Hepatitis B, Hepatitis C, Hepatobiliary Cancers, Hepatobiliary Cancers Liver

Thank you

Trial Information

Genetic Analysis of Liver Cancer


Inclusion Criteria:

3.1.1 Male or female patients 18 years of age and above. 3.1.2 Patients
diagnosed with liver cancer based on biopsy or serum alpha-fetoprotein level, associated
with characteristic hypervascular liver tumors on triphasic spiral CT scan or MRI.
Patients with non-cancer liver conditions such as cirrhosis, adenoma, cholangioma, or
nodular hyperplasia. Patients with metastatic tumor from anther organ, such as metastatic
colon cancer.

3.13 Ability to understand and the willingness to sign a written informed consent
document.

Exclusion Criteria:3.2.1Female patients who are pregnant or nursing will be excluded from
the study.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Samuel So

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

HEP0012

NCT ID:

NCT00768001

Start Date:

June 2008

Completion Date:

October 2011

Related Keywords:

  • Liver Cancer
  • Hepatitis B
  • Hepatitis C
  • Hepatobiliary Cancers
  • Hepatobiliary Cancers Liver
  • Hepatitis
  • Hepatitis A
  • Hepatitis B
  • Hepatitis C
  • Liver Neoplasms

Name

Location

Stanford University School of MedicineStanford, California  94305-5317